Rechercher
Journal Club: Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade S
- Cell: olume 181, ISSUE 4, P905-913.e7, May 14
- 22 juin 2020
- 1 min de lecture
Highlights
Soluble human ACE2 can inhibit SARS-CoV-2 infections
SARS-CoV-2 can directly infect human blood vessel and kidney organoids
Human organoids as model systems to study SARS-CoV-2 infections/COVID-19
Comments